Takeda
Takeda Ventures, established in 2001, is the venture capital arm of Takeda Pharmaceutical Company Limited. Based in Cambridge, Massachusetts, with additional offices in San Diego, California, and globally, the firm specializes in direct and fund-of-fund investments, focusing on seed to mid-stage biotechnology and pharmaceutical companies. Takeda Ventures invests in therapeutics, including cardiovascular, inflammatory, metabolic, and oncological diseases, as well as regenerative medicines and novel technologies like RNA and DNA modulation. It typically invests between $0.25 million to $5 million, preferring minority stakes and board observer roles, and co-invests with other venture capital firms. Additionally, Takeda Ventures facilitates preclinical therapeutic discovery alliances and invests in digital health companies that improve patient outcomes and care delivery.
Past deals in Mozambique
VillageReach
Grant in 2024
VillageReach is an international NGO headquartered in Seattle, WA with field offices located in Malawi and Mozambique, Africa. Through collaboration with public and private sector partners, VillageReach seeks to increase access to quality healthcare for the world most underserved communities, bringing life-saving innovations to scale and sustainability. VillageReach develops, tests and implements solutions that uniquely address barriers at the lower levels or last mileĀ of healthcare delivery in low-resource communities including medicine availability, human resource constraints, data visibility and lack of infrastructure.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.